SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Income Statement
FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 954.68M | 957.09M | 898.60M | 821.10M | 648.70M | |||
| Minority Interest Expense | -644.00K | -660.00K | -92.00K | -500.00K | -400.00K | |||
| Cost Of Goods | 639.25M | 634.48M | 582.11M | 524.70M | 422.50M | |||
| Gross Profit | 315.43M | 322.61M | 316.49M | 296.40M | 226.20M | |||
| Operating Expenses | 155.31M | 132.02M | 145.31M | 128.40M | 111.30M | |||
| Research and Development | 25.05M | 24.25M | 26.82M | 23.50M | 22.30M | |||
| Selling, General, and Administrative Expenses | 125.48M | 125.46M | 125.51M | 110.70M | 93.00M | |||
| Operating Income | 160.12M | 190.59M | 171.17M | 168.10M | 114.90M | |||
| Interest Income/Expense | 4.86M | -617.00K | 16.68M | 0.00 | 8.40M | |||
| Other Income/Expense | -943.00K | -6.58M | -8.81M | -100.00K | -500.00K | |||
| Non Recurring Items | N/A | 585.00K | 6.75M | -9.70M | 500.00K | |||
| Income Before Taxes | 164.23M | 183.97M | 185.80M | 158.30M | 123.30M | |||
| Income Tax | 29.42M | 33.63M | 33.87M | 32.40M | 22.10M | |||
| Net Income | 134.17M | 149.69M | 151.84M | 125.40M | 100.80M | |||
| EBITDA | 229.00M | 255.56M | 217.82M | 223.50M | 151.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.89 | 0.99 | 1.01 | 0.83 | 0.67 | |||
| Non GAAP EPS | N/A | 0.99 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 33.04% | 33.71% | 35.22% | 36.10% | 34.87% | |||
| Profit Margin | 14.05% | 15.64% | 16.90% | 15.27% | 15.54% | |||
| Operating Profit Margin | 16.77% | 19.91% | 19.05% | 20.47% | 17.71% | |||
All data in EUR